These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 21651905)

  • 1. Endothelial angiotensin-converting enzyme and neutral endopeptidase in isolated human umbilical vein: an effective bradykinin inactivation pathway.
    Nowak W; Errasti AE; Armesto AR; Santín Velazque NL; Rothlin RP
    Eur J Pharmacol; 2011 Sep; 667(1-3):271-7. PubMed ID: 21651905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional evidence of des-Arg10-kallidin enzymatic inactivating pathway in isolated human umbilical vein.
    Nowak W; Goldschmidt ED; Falcioni AG; Pugliese MI; Errasti AE; Pelorosso FG; Daray FM; Gago JE; Rothlin RP
    Naunyn Schmiedebergs Arch Pharmacol; 2007 May; 375(3):221-9. PubMed ID: 17372720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bradykinin degrading activity in cultured human endothelial cells.
    Graf K; Gräfe M; Auch-Schwelk W; Baumgarten CR; Bossaller C; Fleck E
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S16-20. PubMed ID: 1282624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of ACE and NEP in bradykinin-induced relaxation and contraction response of isolated porcine basilar artery.
    Miyamoto A; Murata S; Nishio A
    Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):365-70. PubMed ID: 12012022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of des-Arg9-kallidin-induced vasoconstrictor responses by metallopeptidase inhibition in isolated human umbilical artery.
    Pelorosso FG; Brodsky PT; Zold CL; Rothlin RP
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1355-60. PubMed ID: 15764737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutral endopeptidase up-regulation in isolated human umbilical artery: involvement in desensitization of bradykinin-induced vasoconstrictor effects.
    Pelorosso FG; Halperin AV; Palma AM; Nowak W; Errasti AE; Rothlin RP
    J Pharmacol Exp Ther; 2007 Feb; 320(2):713-20. PubMed ID: 17085545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degradation of bradykinin by neutral endopeptidase (EC 3.4.24.11) in cultured human endothelial cells.
    Graf K; Gräfe M; Bossaller C; Niehus J; Schulz KD; Auch-Schwelk W; Fleck E
    Eur J Clin Chem Clin Biochem; 1993 May; 31(5):267-72. PubMed ID: 8395230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelium-derived bradykinin: implications for angiotensin-converting enzyme-inhibitor therapy.
    Busse R; Fleming I; Hecker M
    J Cardiovasc Pharmacol; 1993; 22 Suppl 5():S31-6. PubMed ID: 7508049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Renal vascular responses of bradykinin in the isolated rat kidney].
    Bagate K; Develioglu L; Michel B; Grima M; Imbs JL; Barthelmebs M
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1131-4. PubMed ID: 9404422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutral endopeptidase and angiotensin converting enzyme inhibitors potentiate kinin-induced contraction of ferret trachea.
    Dusser DJ; Nadel JA; Sekizawa K; Graf PD; Borson DB
    J Pharmacol Exp Ther; 1988 Feb; 244(2):531-6. PubMed ID: 3279179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of metallopeptidases and kinin receptors in swine oropharyngeal tissues: effects of angiotensin I-converting enzyme inhibition and inflammation.
    Moreau ME; Dubreuil P; Molinaro G; Chagnon M; Müller-Esterl W; Lepage Y; Marceau F; Adam A
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1065-74. PubMed ID: 16166273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of acute angiotensin-converting enzyme and neutral endopeptidase 24.11 inhibition on plasma extravasation in the rat.
    Sulpizio AC; Pullen MA; Edwards RM; Brooks DP
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1141-7. PubMed ID: 14769834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutral endopeptidase inhibition augments vascular actions of bradykinin in patients treated with angiotensin-converting enzyme inhibition.
    Cruden NL; Fox KA; Ludlam CA; Johnston NR; Newby DE
    Hypertension; 2004 Dec; 44(6):913-8. PubMed ID: 15492133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of vasoactive peptides by human endothelial cells in culture. Angiotensin I converting enzyme (kininase II) and angiotensinase.
    Johnson AR; Erdös EG
    J Clin Invest; 1977 Apr; 59(4):684-95. PubMed ID: 191471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a dual inhibitor of angiotensin I-converting enzyme and neutral endopeptidase.
    French JF; Flynn GA; Giroux EL; Mehdi S; Anderson B; Beach DC; Koehl JR; Dage RC
    J Pharmacol Exp Ther; 1994 Jan; 268(1):180-6. PubMed ID: 8301555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries.
    Sivieri DO; Bispo-da-Silva LB; Oliveira EB; Resende AC; Salgado MC
    Hypertension; 2007 Jul; 50(1):110-5. PubMed ID: 17470724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.
    Campbell DJ; Anastasopoulos F; Duncan AM; James GM; Kladis A; Briscoe TA
    J Pharmacol Exp Ther; 1998 Nov; 287(2):567-77. PubMed ID: 9808682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kininase-independent potentiation of endothelium-dependent relaxations to kinins by converting enzyme inhibitor perindoprilat.
    Mombouli JV; Ballard KD; Vanhoutte PM
    Acta Pharmacol Sin; 2002 Mar; 23(3):203-7. PubMed ID: 11918842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of the renal responses to bradykinin by inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in anesthetized dogs.
    Seymour AA; Sheldon JH; Smith PL; Asaad M; Rogers WL
    J Pharmacol Exp Ther; 1994 Apr; 269(1):263-70. PubMed ID: 8169834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.